Levin AA - Search Results

1

CpG and Non-CpG oligodeoxynucleotides induce differential proinflammatory gene expression profiles in liver and peripheral blood leukocytes in mice.

Younis HS, Vickers T, Levin AA, Henry SP. Younis HS, et al. Among authors: levin aa. J Immunotoxicol. 2006 Jul 1;3(2):57-68. doi: 10.1080/15476910600718236. J Immunotoxicol. 2006. PMID: 18958686 Free article.

2

Assessment of the effects of ISIS 2302, an anti-sense inhibitor of human ICAM-1, on cellular and humoral immunity in mice.

Henry SP, Levin AA, White K, Mennear JH. Henry SP, et al. Among authors: levin aa. J Immunotoxicol. 2006 Dec 1;3(4):199-211. doi: 10.1080/15476910601046538. J Immunotoxicol. 2006. PMID: 18958701 Free article.

3

Effects of an antisense oligonucleotide inhibitor of human ICAM-1 on fetal development in rabbits.

Henry SP, Denny KH, Templin MV, Yu RZ, Levin AA. Henry SP, et al. Among authors: levin aa. Birth Defects Res B Dev Reprod Toxicol. 2004 Dec;71(6):368-73. doi: 10.1002/bdrb.20024. Birth Defects Res B Dev Reprod Toxicol. 2004. PMID: 15617022

4

Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents.

Monteith DK, Henry SP, Howard RB, Flournoy S, Levin AA, Bennett CF, Crooke ST. Monteith DK, et al. Among authors: levin aa. Anticancer Drug Des. 1997 Jul;12(5):421-32. Anticancer Drug Des. 1997. PMID: 9236857

5

Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide.

Henry SP, Beattie G, Yeh G, Chappel A, Giclas P, Mortari A, Jagels MA, Kornbrust DJ, Levin AA. Henry SP, et al. Among authors: levin aa. Int Immunopharmacol. 2002 Nov;2(12):1657-66. doi: 10.1016/s1567-5769(02)00142-x. Int Immunopharmacol. 2002. PMID: 12469940

6

Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species.

Geary RS, Yu RZ, Watanabe T, Henry SP, Hardee GE, Chappell A, Matson J, Sasmor H, Cummins L, Levin AA. Geary RS, et al. Among authors: levin aa. Drug Metab Dispos. 2003 Nov;31(11):1419-28. doi: 10.1124/dmd.31.11.1419. Drug Metab Dispos. 2003. PMID: 14570775

7

Effects of human and murine antisense oligonucleotide inhibitors of ICAM-1 on reproductive performance, fetal development, and post-natal development in mice.

Henry SP, Denny KH, Templin MV, Yu RZ, Levin AA. Henry SP, et al. Among authors: levin aa. Birth Defects Res B Dev Reprod Toxicol. 2004 Dec;71(6):359-67. doi: 10.1002/bdrb.20023. Birth Defects Res B Dev Reprod Toxicol. 2004. PMID: 15617021

8

Antisense oligonucleotide inhibitors for the treatment of cancer: 2. Toxicological properties of phosphorothioate oligodeoxynucleotides.

Henry SP, Monteith D, Levin AA. Henry SP, et al. Among authors: levin aa. Anticancer Drug Des. 1997 Jul;12(5):395-408. Anticancer Drug Des. 1997. PMID: 9236855 Review. No abstract available.

9

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice.

Henry SP, Taylor J, Midgley L, Levin AA, Kornbrust DJ. Henry SP, et al. Among authors: levin aa. Antisense Nucleic Acid Drug Dev. 1997 Oct;7(5):473-81. doi: 10.1089/oli.1.1997.7.473. Antisense Nucleic Acid Drug Dev. 1997. PMID: 9361906

10

Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1.

Henry SP, Templin MV, Gillett N, Rojko J, Levin AA. Henry SP, et al. Among authors: levin aa. Toxicol Pathol. 1999 Jan-Feb;27(1):95-100. doi: 10.1177/019262339902700117. Toxicol Pathol. 1999. PMID: 10367680 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters